19:41 , Nov 21, 2018 |  BioCentury  |  Finance

Alphamab's cancer cash

Alphamab Oncology spun out from Suzhou Alphamab Co. Ltd. and raised more than $100 million in a series A round to advance multiple cancer biologics through clinical testing. Investors in the round, which closed on...
23:22 , Nov 16, 2018 |  BC Extra  |  Financial News

Alphamab Oncology raises more than $100M series A

Immuno-oncology company Alphamab Oncology (Cayman) raised over $100 million in a series A round to accelerate development of its biologics including lead product KN035. Advantech Capital, PAG, China Venture Capital Fund, OrbiMed Advisors, Heritage Provider...
18:58 , Jul 13, 2018 |  BC Week In Review  |  Financial News

Sinovac Terminates Take-Private Deal, Raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said July 3 it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board...
18:09 , Jul 3, 2018 |  BC Extra  |  Financial News

Sinovac terminates take-private deal, raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board determined that...
19:25 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Harbour BioMed raises undisclosed series A+

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round on Jan. 22 led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co....
00:08 , Jan 23, 2018 |  BC Extra  |  Financial News

CDH leads Harbour BioMed round

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co. Ltd. rights to...
19:08 , Jan 19, 2018 |  BioCentury  |  Finance

Incubating in China

C-Bridge Capital is one of the newer venture funds in Chinese healthcare seeking to bring mature platforms or programs from the Western market into China. Compared with most other Chinese VCs, however, C-Bridge is investing...
21:20 , Jan 5, 2018 |  BC Week In Review  |  Financial News

DTRM Biopharma closes series A round

Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more than $60 million, with components in two currencies. The round included a $45.9 million component led by Advantech...
20:45 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Chinese biotech KBP raises $76 million series A

KBP Biosciences Co. Ltd. (Jinan, China) raised a $76 million series A round on Jan. 5 co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay City Capital...
13:06 , Jan 5, 2018 |  BC Extra  |  Financial News

Chinese biotech KBP raises $76 million series A

KBP Biosciences Co. Ltd. (Jinan, China) raised a $76 million series A round co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay City Capital GF XINDE Life...